Multisystem inflammatory syndrome in children (MIS-C)
Inflammatory · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Post-infectious hyperinflammatory syndrome (often weeks after SARS-CoV-2) with fever, shock, GI symptoms and cardiac dysfunction; overlaps with Kawasaki disease.
Red flags
- Shock
- Ventricular dysfunction / arrhythmia
- Coronary artery dilatation
- Rapid deterioration
Assessment
Differential diagnosis
- Kawasaki disease
- Toxic shock syndrome
- Bacterial sepsis
- Myocarditis
- Appendicitis / acute abdomen
Investigations
- FBC, CRP, ferritin, LDH
- Troponin and natriuretic peptide, ECG, echocardiography
- Coagulation and D-dimer
- Blood cultures and SARS-CoV-2 serology
- U&E, LFTs, lactate
Management
- Assess for shock and treat with careful fluid resuscitation
- Early inotropes if fluid-refractory (watch cardiac function)
- Send inflammatory and cardiac markers
- Echocardiography for coronary and ventricular function
- Start immunomodulation with specialist input
- Admit to paediatric critical care
Drugs & doses
IVIG
Corticosteroids
Aspirin (Kawasaki-like features)
Inotropes / vasopressors as needed
Disposition
Paediatric critical care.
Complications & pitfalls
- Cardiogenic shock
- Coronary artery aneurysm
- Arrhythmia
- Multiorgan failure
Exam pearls
- Cardiac dysfunction can dominate; fluid boluses may worsen it.
- Consider it in a child with fever, shock and prior COVID-19 exposure.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.